These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19779356)

  • 1. Genetic and functional mitochondrial assessment of HIV-infected patients developing HAART-related hyperlactatemia.
    Garrabou G; Morén C; Gallego-Escuredo JM; Milinkovic A; Villarroya F; Negredo E; Giralt M; Vidal F; Pedrol E; Martínez E; Cardellach F; Gatell JM; Miró O
    J Acquir Immune Defic Syndr; 2009 Dec; 52(4):443-51. PubMed ID: 19779356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART.
    Morén C; Noguera-Julian A; Rovira N; Garrabou G; Nicolàs M; Cardellach F; Martínez E; Sánchez E; Miró O; Fortuny C
    Antivir Ther; 2011; 16(5):719-24. PubMed ID: 21817193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.
    Montaner JS; Côté HC; Harris M; Hogg RS; Yip B; Chan JW; Harrigan PR; O'Shaughnessy MV
    J Acquir Immune Defic Syndr; 2003 Sep; 34 Suppl 1():S85-90. PubMed ID: 14562863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
    Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J
    J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial disturbances in HIV pregnancies.
    Morén C; Noguera-Julián A; Garrabou G; Rovira N; Catalán M; Bañó M; Guitart-Mampel M; Tobías E; Hernández S; Cardellach F; Miró Ò; Fortuny C
    AIDS; 2015 Jan; 29(1):5-12. PubMed ID: 25268887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.
    Pace CS; Martin AM; Hammond EL; Mamotte CD; Nolan DA; Mallal SA
    Antivir Ther; 2003 Aug; 8(4):323-31. PubMed ID: 14518702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial evolution in HIV-infected children receiving first- or second-generation nucleoside analogues.
    Morén C; Noguera-Julian A; Garrabou G; Catalán M; Rovira N; Tobías E; Cardellach F; Miró Ò; Fortuny C
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):111-6. PubMed ID: 22362155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short communication: reversible mitochondrial respiratory chain impairment during symptomatic hyperlactatemia associated with antiretroviral therapy.
    Miró O; López S; Martínez E; Rodríguez-Santiago B; Blanco JL; Milinkovic A; Miró JM; Nunes V; Casademont J; Gatell JM; Cardellach F
    AIDS Res Hum Retroviruses; 2003 Nov; 19(11):1027-32. PubMed ID: 14678610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line therapy and mitochondrial damage: different nucleosides, different findings.
    Blanco F; García-Benayas T; José de la Cruz J; González-Lahoz J; Soriano V
    HIV Clin Trials; 2003; 4(1):11-9. PubMed ID: 12577192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
    Noguera A; Fortuny C; Muñoz-Almagro C; Sanchez E; Vilaseca MA; Artuch R; Pou J; Jimenez R
    Pediatrics; 2004 Nov; 114(5):e598-603. PubMed ID: 15492359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women.
    López S; Coll O; Durban M; Hernàndez S; Vidal R; Suy A; Morén C; Casademont J; Cardellach F; Mataró D; Miró O; Garrabou G
    Antivir Ther; 2008; 13(6):833-8. PubMed ID: 18839784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial impact of human immunodeficiency virus and antiretrovirals on infected pediatric patients with or without lipodystrophy.
    Morén C; Noguera-Julian A; Rovira N; Corrales E; Garrabou G; Hernández S; Nicolás M; Tobías E; Cardellach F; Miró O; Fortuny C
    Pediatr Infect Dis J; 2011 Nov; 30(11):992-5. PubMed ID: 21697766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients.
    Chiappini F; Teicher E; Saffroy R; Pham P; Falissard B; Barrier A; Chevalier S; Debuire B; Vittecoq D; Lemoine A
    Lab Invest; 2004 Jul; 84(7):908-14. PubMed ID: 15122308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy.
    Shikuma CM; Hu N; Milne C; Yost F; Waslien C; Shimizu S; Shiramizu B
    AIDS; 2001 Sep; 15(14):1801-9. PubMed ID: 11579242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.
    Côté HC; Brumme ZL; Craib KJ; Alexander CS; Wynhoven B; Ting L; Wong H; Harris M; Harrigan PR; O'Shaughnessy MV; Montaner JS
    N Engl J Med; 2002 Mar; 346(11):811-20. PubMed ID: 11893792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients.
    Ciccosanti F; Corazzari M; Soldani F; Matarrese P; Pagliarini V; Iadevaia V; Tinari A; Zaccarelli M; Perfettini JL; Malorni W; Kroemer G; Antinori A; Fimia GM; Piacentini M
    Antivir Ther; 2010; 15(3):377-90. PubMed ID: 20516557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance in mitochondrial dynamics and apoptosis in pregnancies among HIV-infected women on HAART with obstetric complications.
    Guitart-Mampel M; Hernandez AS; Moren C; Catalan-Garcia M; Tobias E; Gonzalez-Casacuberta I; Juarez-Flores DL; Gatell JM; Cardellach F; Milisenda JC; Grau JM; Gratacos E; Figueras F; Garrabou G
    J Antimicrob Chemother; 2017 Sep; 72(9):2578-2586. PubMed ID: 28859443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.
    Côté HC; Magil AB; Harris M; Scarth BJ; Gadawski I; Wang N; Yu E; Yip B; Zalunardo N; Werb R; Hogg R; Harrigan PR; Montaner JS
    Antivir Ther; 2006; 11(1):79-86. PubMed ID: 16518963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.
    Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA
    Antivir Ther; 2009; 14(3):331-8. PubMed ID: 19474467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy.
    Miró O; López S; Pedrol E; Rodríguez-Santiago B; Martínez E; Soler A; Milinkovic A; Casademont J; Nunes V; Gatell JM; Cardellach F
    Antivir Ther; 2003 Aug; 8(4):333-8. PubMed ID: 14526764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.